Clinical Trial Update: Gum Arabic as Anti-oxidant, Anti-inflammatory and Fetal Hemoglobin Inducing Agent in Sickle Cell Anemia Patients [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial exploring gum arabic as an antioxidant, anti-inflammatory, and fetal hemoglobin inducer in children with sickle cell anemia; phase 2 and phase 3 …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Anemia in Children

Drugs mentioned

• Gum Arabic (arabic gum)

Snippet

Sponsor: Al-Neelain University | Conditions: Sickle Cell Anemia in Children | Phase 2, Phase 3 | Status: UNKNOWN